An update of genetic basis of PCOS pathogenesis.

  title={An update of genetic basis of PCOS pathogenesis.},
  author={Raiane P Crespo and Tania A. S. S. Bachega and Berenice Bilharinho de Mendonca and Larissa Garcia Gomes},
  journal={Archives of endocrinology and metabolism},
  volume={62 3},
Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder that affects 5-20% of reproductive age women. PCOS clinical symptoms include hirsutism, menstrual dysfunction, infertility, obesity and metabolic syndrome. There is a wide heterogeneity in clinical manifestations and metabolic complications. The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen secretion… 

Figures and Tables from this paper

Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives

The present study discusses the clinical spectrum, the genetics, and the variants identified as being associated with PCOS, and discusses the current status of the treatment modalities, which is important to find new ways of treatment.

Hyperandrogenic origins of polycystic ovary syndrome – implications for pathophysiology and therapy

Monkey models are most comprehensive, while mouse models provide molecular insight, including identifying the androgen receptor, particularly in neurons, as mediating androgen-induced PCOS-like programming.

Current concepts of polycystic ovary syndrome pathogenesis

A model for understanding polycystic ovary syndrome (PCOS) pathophysiology is provided and the evidence on which it is based is updated and complimentary molecular genetic and epigenetic advances in understanding PCOS cause are highlighted.

Survey based on classification of PCOS using gene expression

The different genes involved in causes of PCOS and hormone factors associated with the PCOS are surveyed to prevent from inheritance to next generations.

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies

Much work remains to identify causal variants and functional relevance of genes associated with PCOS, and to identify limitations of the current literature and important methodological considerations for future genetic studies.

Polycystic ovary syndrome (PCOS) - risk factor, diagnostic and current treatment

PCOS is a complex disorder involving many organs and affecting many body functions and it is important to diagnose this disease as soon as possible in order to implement appropriately selected therapeutic treatment aimed at eliminating disease symptoms and reducing the systemic consequences of hyperandrogenism in patients.

Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19

It seems that strategies for adapting the intestinal microbiome could help reduce the severity of COVID-19 in women with PCOS with or without NAFLD, MetSy or obesity.


A balanced review of the latest advances and current limitations in knowledge about PCOS is provided while also providing a few clear and simple principles based on current evidence-based clinical guidelines for the proper study of pathogenesis of PCOS.



Genetics of polycystic ovary syndrome

The historical and recent findings of genetic studies of PCOS, such as familial studies, twin studies, and molecular genetic studies, including the results of recent genome wide associated studies are summarized.

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype are identified, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels, and implicate neuroendocrine changes in disease pathogenesis.

Polycystic ovary syndrome

This Primer summarizes the current state of knowledge regarding the epidemiology, mechanisms and pathophysiology, diagnosis, screening and prevention, management and future investigational directions of the disorder.

Functional genomics of PCOS: from GWAS to molecular mechanisms

Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome.

Overall, 12 of 17 genetic variants mapping to the Chinese PCOS loci similar effect size and identical direction in PCOS patients from Northern European ancestry are observed, indicating a common genetic risk profile for PCOS across populations.

Genetic determinants of polycystic ovary syndrome: progress and future directions.

Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts

At least two of the PCOS susceptibility loci identified in the Chinese PCOS GWAS are also associated with PCOS in European derived populations, and are therefore likely to be important in the aetiology of PCOS regardless of ethnicity.

Heritability of polycystic ovary syndrome in a Dutch twin-family study.

A trivariate genetic analysis of oligomenorrhea, acne, and hirsutism confirmed that the familial component in PCOS is due to genetic factors, justifying the search for susceptibility genes.

Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry.

The gene products LHCGR and FSHR are likely to be important in the etiology of PCOS, regardless of ethnicity and evidence for association with two independent loci and PCOS is found.

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.

Although no single diagnostic features of PCOS are independently associated with insulin resistance, their combinations, which define PCOS phenotypes, may allow physicians to establish which women should undergo metabolic screening, and there is a scale of metabolic risk among women with PCOS.